Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Pepys

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|December 25, 2009
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
Blood|November 4, 2006
Human plasma fibrinogen is synthesized in the liverGlenys A Tennent, Stephen O Brennan, Arie J Stangou, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
Journal of Molecular Biology|February 13, 2007
Beta-edge interactions in a pentadecameric human antibody V kappa domainLeo C James, Phil C Jones, Airlie McCoy, et al.
Arthritis and Rheumatism|May 29, 2007
Normal circulating serum amyloid P component concentration in systemic sclerosisGlenys A Tennent, Magdalena Dziadzio, Eva Triantafillidou, et al.
Open Biology|July 16, 2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
Circulation Research|December 17, 2013
Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteersThirusha Lane, Nancy Wassef, Stephen Poole, et al.
Molecular Medicine (Cambridge, Mass.)|May 2, 2002
Influenza virus infection is not affected by serum amyloid P componentJeff Herbert, Winston L Hutchinson, Jackie Carr, et al.
British Journal of Haematology|June 26, 2003
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapyHelen J Lachmann, Ruth Gallimore, Julian D Gillmore, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 2, 2014
Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC)Simon E Kolstoe, Michelle C Jenvey, Alan Purvis, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|December 25, 2009
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
Blood|November 4, 2006
Human plasma fibrinogen is synthesized in the liverGlenys A Tennent, Stephen O Brennan, Arie J Stangou, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
Journal of Molecular Biology|February 13, 2007
Beta-edge interactions in a pentadecameric human antibody V kappa domainLeo C James, Phil C Jones, Airlie McCoy, et al.
Arthritis and Rheumatism|May 29, 2007
Normal circulating serum amyloid P component concentration in systemic sclerosisGlenys A Tennent, Magdalena Dziadzio, Eva Triantafillidou, et al.
Open Biology|July 16, 2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disordersA Floriaan Schmidt, Chris Finan, Sandesh Chopade, et al.
Circulation Research|December 17, 2013
Infusion of pharmaceutical-grade natural human C-reactive protein is not proinflammatory in healthy adult human volunteersThirusha Lane, Nancy Wassef, Stephen Poole, et al.
Molecular Medicine (Cambridge, Mass.)|May 2, 2002
Influenza virus infection is not affected by serum amyloid P componentJeff Herbert, Winston L Hutchinson, Jackie Carr, et al.
British Journal of Haematology|June 26, 2003
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapyHelen J Lachmann, Ruth Gallimore, Julian D Gillmore, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 2, 2014
Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC)Simon E Kolstoe, Michelle C Jenvey, Alan Purvis, et al.
Pageof 9